19
Views
2
CrossRef citations to date
0
Altmetric
Original Paper

Nuclear Factor-κB in Middle Ear Epithelial Cells: A Methodological Study Using an ELISA

&
Pages 306-309 | Published online: 08 Jul 2009
 

Abstract

Objective—To contribute to the elucidation of the intracellular mechanisms relating to otitis media with effusion (OME) by detecting and quantifying nuclear factor (NF)-κB in middle ear epithelial cells by means of an ELISA. Material and Methods—Using an ELISA technique, NF-κB was identified and quantified in the cytoplasm of cultured epithelial cells from the rabbit middle ear exposed to a well-known inflammatory stimulus: lipopolysaccharide (LPS). Results—NF-κB was measurable with the ELISA in a concentration range of 16–32 ng/μg total cell protein. LPS caused significant enhancement of NF-κB. Furthermore, the NF-κB concentration increased with the duration of LPS exposure. Western blot analysis confirmed the results obtained by ELISA. Conclusion—Further studies are required to determine the role of NF-κB in initiating and regulating the inflammatory response in the middle ear, including the significance of hyperoxia.

Ovesen T, Barrett TQ. Nuclear factor-κB in middle ear epithelial cells: a methodological study using an ELISA. Acta Otolaryngol 2003; 123: 306–309.

Ovesen T, Barrett TQ. Nuclear factor-κB in middle ear epithelial cells: a methodological study using an ELISA. Acta Otolaryngol 2003; 123: 306–309.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.